文献速递骨肌MR

利用菲立磁增强MRI追踪小型猪软骨缺损中的干细胞植入物

Tracking Stem Cell Implants in Cartilage Defects of Minipigs by Using Ferumoxytol-enhanced MRI.
PubMed 文献 · Radiology · 2019-05-07

本研究在10只哥廷根小型猪膝关节软骨缺损中植入未标记或菲立磁标记的基质相关干细胞植入物(MASI),于第1、2、4、8、12、24周行3.0-T MRI并计算T2弛豫时间。结果显示菲立磁标记的MASI出现显著T2缩短(22.2毫秒±3.2 vs 27.9毫秒±1.8,P<.001),且软骨修复结局与未标记对照无差异(P>.05)。植入后第2周,菲立磁标记的凋亡MASI较活MASI出现铁信号丢失并T2延长(26.6毫秒±4.9 vs 20.8毫秒±5.3,P=.001);2周铁信号丢失与12-24周组织病理诊断的不完全软骨修复相关。

要点

  • 菲立磁标记的MASI在MRI上T2显著缩短,可作为标记追踪的影像依据。
  • 植入后第2周铁信号丢失可早期提示凋亡MASI修复失败。
  • 常规MRI需至第24周才能显示凋亡MASI的软骨缺损修复不完全。

核心结论

  • 菲立磁纳米颗粒标记可在大动物模型中加速MRI对基质相关干细胞植入物成功与失败的诊断。

研究设计与样本

  • 2016年1月至2017年12月,10只哥廷根小型猪(5只雄性、5只雌性;平均年龄6个月±5.1,年龄范围4-20个月)在股骨远端软骨缺损中接受未标记(n=12)或菲立磁标记(n=20)的活与凋亡MASI植入;所有MASI在3.0-T成像设备上于第1、2、4、8、12、24周连续行MRI并计算T2弛豫时间;以MOCART评分(0-100分)、Pineda评分及软骨缺损处胶原2产生的组织病理学定量评估软骨再生结局;采用非配对Wilcoxon秩和检验、线性回归模型、Fisher精确检验和Pearson相关进行比较。

关键影像表现/征象

  • 菲立磁标记的MASI显示显著T2缩短(22.2毫秒±3.2 vs 27.9毫秒±1.8;P<.001)。
  • 菲立磁标记的MASI与未标记对照MASI的软骨修复结局无差异(P>.05)。
  • 植入后第2周,菲立磁标记的凋亡MASI较菲立磁标记的活MASI出现铁信号丢失并T2弛豫时间升高(26.6毫秒±4.9 vs 20.8毫秒±5.3;P=.001)。
  • 常规MRI在24周显示凋亡MASI的软骨缺损修复不完全。
  • 2周时铁信号丢失与12-24周组织病理学诊断的不完全软骨修复相关。

诊断标准与关键数值

  • 以MOCART评分(0-100分)和Pineda评分评估软骨修复结局。
  • 以组织病理学定量软骨缺损处胶原2产生作为参考标准。
  • 菲立磁标记的活MASI与凋亡MASI第2周T2弛豫时间分别为20.8毫秒±5.3与26.6毫秒±4.9(P=.001)。

临床应用与阅片要点

  • 菲立磁标记MASI的T2缩短可作为标记成功追踪的影像征象。
  • 植入后第2周出现铁信号丢失并T2延长提示凋亡MASI,可能早期提示修复失败。
  • 常规MRI对凋亡MASI修复不完全的显示延迟至第24周。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Cartilage repair outcomes of matrix-associated stem cell implants (MASIs) in patients have been highly variable. Conventional MRI cannot help distinguish between grafts that will and grafts that will not repair the underlying cartilage defect until many months after the repair. Purpose To determine if ferumoxytol nanoparticle labeling could be used to depict successful or failed MASIs compared with conventional MRI in a large-animal model. Materials and Methods Between January 2016 and December 2017, 10 Göttingen minipigs (n = 5 male; n = 5 female; mean age, 6 months ± 5.1; age range, 4-20 months) received implants of unlabeled (n = 12) or ferumoxytol-labeled (n = 20) viable and apoptotic MASIs in cartilage defects of the distal femur. All MASIs were serially imaged with MRI on a 3.0-T imaging unit at week 1 and weeks 2, 4, 8, 12, and 24, with calculation of T2 relaxation times. Cartilage regeneration outcomes were assessed by using the MR observation of cartilage repair tissue (MOCART) score (scale, 0-100), the Pineda score, and histopathologic quantification of collagen 2 production in the cartilage defect. Findings were compared by using the unpaired Wilcoxon rank sum test, a linear regression model, the Fisher exact test, and Pearson correlation. Results Ferumoxytol-labeled MASIs showed significant T2 shortening (22.2 msec ± 3.2 vs 27.9 msec ± 1.8; P < .001) and no difference in cartilage repair outcomes compared with unlabeled control MASIs (P > .05). At week 2 after implantation, ferumoxytol-labeled apoptotic MASIs showed a loss of iron signal and higher T2 relaxation times compared with ferumoxytol-labeled viable MASIs (26.6 msec ± 4.9 vs 20.8 msec ± 5.3; P = .001). Standard MRI showed incomplete cartilage defect repair of apoptotic MASIs at 24 weeks. Iron signal loss at 2 weeks correlated with incomplete cartilage repair, diagnosed at histopathologic examination at 12-24 weeks. Conclusion Ferumoxytol nanoparticle labeling can accelerate the diagnosis of successful and failed matrix-associated stem cell implants at MRI in a large-animal model. © RSNA, 2019 Online supplemental material is available for this article. See also the editorial by Sneag and Potter in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Theruvath AJ, Nejadnik H, Lenkov O, et al. Tracking Stem Cell Implants in Cartilage Defects of Minipigs by Using Ferumoxytol-enhanced MRI. Radiology. 2019. PMID: 31063081. doi:10.1148/radiol.2019182176

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。